National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years — United States, 2015

Morbidity and Mortality Weekly Report

Volumn 65, Issue 33, 2016, Pages 850-858

  Reagan Steiner, Sarah ^a   Yankey, David ^a   Jeyarajah, Jenny ^b   Elam Evans, Laurie D ^a   Robinette Curtis, C ^a   Macneil, Jessica ^a   Markowitz, Lauri E ^a   Singleton, James A ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Carter Consulting Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; VACCINE; WART VIRUS VACCINE;

ADOLESCENT; FEMALE; HEALTH CARE SURVEY; HEALTH PROMOTION; HUMAN; IMMUNIZATION; MALE; MOTIVATION; UNITED STATES; UTILIZATION; VACCINATION;

ADOLESCENT; CHICKENPOX VACCINE; FEMALE; GOALS; HEALTH CARE SURVEYS; HEALTHY PEOPLE PROGRAMS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MENINGOCOCCAL VACCINES; PAPILLOMAVIRUS VACCINES; UNITED STATES; VACCINATION; VACCINES; VACCINES, CONJUGATE;

EID: 84983591880     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6533a4     Document Type: Article

References (10)

1. Robinson CL; Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group. ACIP Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years—United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:86-7. http://dx.doi.org/10.15585/mmwr.mm6504a4
2. National Committee for Quality Assurance. NCQA updates quality measures for HEDIS® 2017 (press release). Washington, DC: National Committee for Quality Assurance; 2016. http://www.ncqa.org/newsroom/details/ncqa-updates-quality-measures-for-hedis-2017
3. Viens LJ, Henley SJ, Watson M, et al. Human papillomavirus-associated cancers—United States, 2008-2012. MMWR Morb Mortal Wkly Rep 2016;65:661-6. http://dx.doi.org/10.15585/mmwr.mm6526a1
4. Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE. The estimated impact of human papillomavirus vaccine coverage on the lifetime cervical cancer burden among girls currently aged 12 years and younger in the United States. Sex Transm Dis 2014;41:656-9. http://dx.doi.org/10.1097/OLQ.0000000000000199
5. Allison MA, Hurley LP, Markowitz L, et al. Primary care physicians’ perspectives about HPV vaccine. Pediatrics 2016;137:e20152488. http://dx.doi.org/10.1542/peds.2015-2488
6. Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev 2015;24:1673-9. http://dx.doi.org/10.1158/1055-9965.EPI-15-0326
7. Healy CM, Montesinos DP, Middleman AB. Parent and provider perspectives on immunization: are providers overestimating parental concerns? Vaccine 2014;32:579-84. http://dx.doi.org/10.1016/j.vaccine.2013.11.076
8. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2014. MMWR Morb Mortal Wkly Rep 2015;64:784-92. http://dx.doi.org/10.15585/mmwr.mm6429a3
9. Community Preventive Services Task Force. The community guide—guide to community preventive services: increasing appropriate vaccination. Atlanta, GA: Community Preventive Services Task Force; 2016. http://www.thecommunityguide.org/vaccines/index.html
10. Smulian EA, Mitchell KR, Stokley S. Interventions to increase HPV vaccination coverage: a systematic review. Hum Vaccin Immunother 2016;12:1566-88. http://dx.doi.org/10.1080/21645515.2015.1125055